Intuitive Surgical (ISRG) Cash from Investing Activities (2009 - 2026)
Intuitive Surgical (ISRG) posted Cash from Investing Activities of -$26.6 million for Q2 2026, up 97.09% on a QoQ basis from -$914.5 million in Q1 2026, and down 110.2% year-over-year from $260.7 million in Q2 2025.
Analysis
Intuitive Surgical (ISRG) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Intuitive Surgical has reported Cash from Investing Activities for 18 years, with the latest figure at -$26.6 million in Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 110.2% year-over-year to -$26.6 million in Q2 2026; TTM through Jun 2026 was -$749.5 million, a 65.98% increase from a year earlier, with the FY2025 full-year figure at $665.8 million, up 120.34% from the prior year.
- Cash from Investing Activities was -$26.6 million for Q2 2026 at Intuitive Surgical, up from -$914.5 million in the prior quarter.
- The five-year high for Cash from Investing Activities was $574.8 million in Q4 2022, with the low at -$1.4 billion in Q3 2024.
- Average Cash from Investing Activities over 5 years is -$141.0 million, with a median of -$77.6 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2026: Cash from Investing Activities soared 366.93% in 2023, then sank 528.34% in 2026.
- Over 5 years, Cash from Investing Activities stood at $574.8 million in 2022, then tumbled by 281.66% to -$1.0 billion in 2023, then fell by 21.07% to -$1.3 billion in 2024, then jumped by 83.44% to -$209.4 million in 2025, then surged by 87.3% to -$26.6 million in 2026.
- The last three Cash from Investing Activities figures came in at -$26.6 million (Q2 2026), -$914.5 million (Q1 2026), and -$209.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 329.80 Mn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | -383.65 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | -222.00 Mn |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn | -108.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.60 Mn |
| Mar 31, 2026 | -914.50 Mn |
| Dec 31, 2025 | -209.40 Mn |
| Sep 30, 2025 | 401.00 Mn |
| Jun 30, 2025 | 260.70 Mn |
| Mar 31, 2025 | 213.50 Mn |
| Dec 31, 2024 | -1.26 Bn |
| Sep 30, 2024 | -1.41 Bn |
| Jun 30, 2024 | -467.10 Mn |
| Mar 31, 2024 | -128.50 Mn |
| Dec 31, 2023 | -1.04 Bn |
| Sep 30, 2023 | -446.60 Mn |
| Jun 30, 2023 | 557.60 Mn |
| Mar 31, 2023 | 573.10 Mn |
| Dec 31, 2022 | 574.80 Mn |
| Sep 30, 2022 | 544.50 Mn |
| Jun 30, 2022 | 466.20 Mn |
| Mar 31, 2022 | -214.70 Mn |
| Dec 31, 2021 | -641.00 Mn |
| Sep 30, 2021 | -838.80 Mn |